C12Y 103/08
Oxidoreductases acting on the ch-ch group of donors: with flavin as acceptor
Official title: with flavin as acceptor (1.3.8)
C12Y103/08 (Oxidoreductases acting on the ch-ch group of donors: with flavin as acceptor) appears on 14 US grants and 43 published applications in this corpus.
Search patents in C12Y- Granted patents
- 14
- Published applications
- 43
- Assignees
- 24
- Inventors
- 83
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 2 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 2 | 4 |
| 2017 | 3 | 3 |
| 2018 | 0 | 4 |
| 2019 | 2 | 5 |
| 2020 | 1 | 2 |
| 2021 | 0 | 4 |
| 2022 | 1 | 1 |
| 2023 | 3 | 3 |
| 2024 | 0 | 5 |
| 2025 | 2 | 4 |
| 2026 | 0 | 4 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Y 103/08001Butyryl-coa dehydrogenase , i.e. short chain acyl-coa dehydrogenase4
- C12Y 103/08004Isovaleryl-coa dehydrogenase2
- C12Y 103/08009Very-long-chain acyl-coa dehydrogenase2
- C12Y 103/08006Glutaryl-coa dehydrogenase1
- C12Y 103/08007Medium-chain acyl-coa dehydrogenase1
- C12Y 103/080024,4'-diapophytoene desaturase0
- C12Y 103/08003-benzylsuccinyl-coa dehydrogenase0
- C12Y 103/080052-methyl-branched-chain-enoyl-coa reductase0
All 9 subgroupsShow fewer
Recent patents
- Recombinant AAV vectors for treating glutaric aciduria type I9 Dec 2025US 12,491,266 B2Shanghai Vitalgen Biopharma Co., Ltd.
- Compositions, assays, and methods for direct modulation of fatty acid metabolism22 Jul 2025US 12,366,576 B2Dana-Farber Cancer Institute, Inc.
- Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier27 Jun 2023US 11,685,925 B2Synlogic Operating Company, Inc.
- Compositions, assays, and methods for direct modulation of fatty acid metabolism31 Jan 2023US 11,567,082 B2Dana-Farber Cancer Institute, Inc.
- Animal cell, method for producing animal cell, and method for producing target protein3 Jan 2023US 11,542,523 B2FUJIFILM Corporation
- Production of cannabinoids and engineered cells therefor23 Jul 2026US 2026/0209780 A1Cellibre, Inc.
- Production method for product14 May 2026US 2026/0132438 A1FUJIFILM Corporation
- In Vitro Bioproduction of Specific Chain Legnth Poly(hydroxyalkanoate) Monomers9 Apr 2026US 2026/0098283 A1Kimberly-Clark Worldwide, Inc.
- Method for constructing l-valine producing strain, l-valine producing strain and use thereof29 Jan 2026US 2026/0028652 A1Shandong University
- Enzymes, cells, and methods for producing cis-3 hexenol20 Nov 2025US 2025/0354180 A1Manus Bio Inc.
Most cited
By later US patents
- Methods for biosynthesizing 1,3 butadiene15US 9,422,578 B2Invista North America S A R L · 2016
- Methods for biosynthesizing 1,3 butadiene14US 9,422,580 B2Invista North America S A R L · 2016
- Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier12US 10,273,489 B2Synlogic Operating Company, Inc. · 2019
- Methods, cells and reagents for production of isoprene, derivatives and intermediates thereof3US 10,167,487 B2Invista North America S A R L · 2019
- Methods of producing four carbon molecules3US 9,663,801 B2Invista North America S A R L · 2017